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Contrary to our abundant knowledge about the sensiti-
zation phase of human contact hypersensitivity, little is
known about the cell types orchestrating the e¡ector
phase. In order to address this issue, we phenotypically
analyzed biopsies from 72 h epicutaneous patch test re-
actions (n¼10) and normal human skin (n¼ 5) for the
presence of various leukocyte di¡erentiation antigens.
The in£ammatory in¢ltrate was dominated by CD3þ/
CD4þ Tcells with approximately 30% of the cells coex-
pressing CD25 and CTLA-4, a phenotype consistent
with either activated e¡ector or regulatory T cells. In
our search for professional antigen-presenting cells, we
were surprised to ¢nd not only sizeable numbers of
CD1aþ dendritic cells and CD1cþ dendritic cells, but
also of CD123þ, CD45RAþ , BDCA-2þ , CLAþ , and
CD62Lþ plasmacytoid dendritic cells. Although vir-
tually absent in normal human skin, these cells were
detectable already 6 h after hapten challenge and were
often found in close proximity to CD56þ natural killer
cells, indicative of a functional interaction between
these cell types. The detailed knowledge of the cellular
composition of the in£ammatory in¢ltrate in allergic
contact dermatitis and its kinetics should form the basis
for the investigation of the immunologic and molecular
events operative in the perpetuation and resolution of
the eczematous response. Key words: allergic contact der-
matitis/dermal dendritic cells/immuno£uorescence/Langerhans
cells/plasmacytoid dendritic cells/regulatory T cells. J Invest
Dermatol 121:1409 ^1418, 2003
A
llergic contact dermatitis (ACD) is aT cell mediated
cutaneous immune response to low-molecular-
weight chemicals termed haptens (Belsito, 1999).
Upon contact, haptens penetrate the skin and can
then be covalently attached to amino acid residues
on proteins or to the major histocompatibility complex (MHC)
molecule itself (Martin and Weltzien, 1994). Resident antigen-
presenting cells, i.e., Langerhans cells or dermal dendritic cells
(DDC), internalize the hapten, migrate to regional lymph nodes
and present the hapten-bound MHC^peptide complex to na|«veT
cells. This sensitization phase leads to hapten-speci¢c MHC class
I- and/or class II-restricted T cell proliferation.
Re-exposure of a sensitized individual to a relevant hapten eli-
cits the e¡ector phase of contact hypersensitivity (CHS), which
clinically results in eczema. Contrary to the ample knowledge
about the sensitization phase, only little is known about the me-
chanisms guiding and governing the e¡ector phase.
It has long been assumed that hapten-speci¢c CD4þ Tcells are
the critical e¡ector cells in CHS (Sinigaglia et al, 1985; Cher and
Mosmann, 1987). As these CD4þ T cells were found to produce
mainlyT1 cytokines (interferon-g and interleukin (IL)-2), allergic
eczema was classi¢ed as a T1-mediated response (Sinigaglia et al,
1985; Kapsenberg et al, 1992). More recent studies in mice and hu-
mans, however, yielded controversial data raising the question as
to what extent the allergic tissue reaction is propagated byT1 or
T2 cells and by CD4 or CD8 Tcells (Gocinski andTigelaar, 1990;
Probst et al, 1995; Xu et al, 1996;Werfel et al, 1997; Cavani et al, 1998;
Wang et al, 2000). Particularly intriguing was the observation of
nickel-speci¢c CD8þ T1 cells in nickel-allergic individuals only,
whereas nickel-speci¢c CD4þ T cells were isolated from the
blood of both allergic and nonallergic persons (Probst et al, 1995;
Cavani et al, 1998). This could indicate that a nonallergic state of a
given individual does not necessarily result from a lack of anti-
genic contact, but is rather a consequence of active suppres-
sion of hapten-speci¢c e¡ector cells by IL-10-secreting CD4þ
regulatory T cells. As these cells have the capacity to block DC-
dependent hapten-speci¢c T cell responses, they may be crucial
for terminating the eczematous reaction in allergic individuals.
(Cavani et al, 2000).
The elicitation of ACD presumably requires close interactions
between in¢ltrating T cells and antigen-presenting cells, which
either reside in the skin or migrate from blood. The nature of
the antigen-presenting cell type supportingT cell mediated tissue
in£ammation remains elusive. Although Langerhans cells/DDC
were thought to be the major players in this process (Romani
and Schuler, 1992), other evidence exists that depletion of resident
Langerhans cells after sensitization in mice results in an increased,
and not a decreased, CHS response (Grabbe et al, 1995).
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There also exist anecdotal observations on numerical, phenoty-
pic, and/or functional changes in cells/molecules of the innate im-
mune system.
Given all these controversial results concerning the nature of
cells being centrally involved in its development and resolution,
ACD is probably a much more complex event than previously
thought. In this study we immunophenotypically characterized
the leukocytic in¢ltrate of allergic patch test reactions at various
stages of development, focusing particularly on DC and T cell
subsets as well as on members of the innate immune system. By
doing so, we sought to gain useful information about kinetics,
quality, and quantity of the in£ammatory tissue response opera-
tive in allergic eczema.
MATERIALS AND METHODS
Patients and tissue material This study was performed in accordance
with the guidelines of the Declaration of Helsinki. After approval of the
investigational protocol by the institute and the local Ethics committee of
Vienna University’s Medical School, 10 patients with positive epicutaneous
patch tests (EPT) to nickel (n¼ 5) or fragrance mix (n¼ 5) were enrolled
in the study after giving their informed consent. The allergens were
applied for 6 h, 24 h, 48 h, and 72 h on the patients’ upper back via
standardized patch tests. After the indicated time points, one 4 mm punch
biopsy of the allergic patch test reaction was taken under local anesthesia
from each test person. All reactions were classi¢ed using the criteria of
the International Contact Dermatitis Research Group and ranged between
1 and 3, according to the state of in£ammation. Normal skin biopsies (NS)
from healthy volunteers (n¼ 5) were used as the control group.
The biopsies were embedded in OCT Tissue-Tek (Sakura Finetek
Europe B.V. Zoeterwoude, The Netherlands), snap-frozen in liquid
nitrogen, and stored at ^801C until further processing.
Immuno£uorescence staining Frozen tissue was cut into 5 mm thick
sections and mounted on capillary gap microscope slides (DAKO,
Glostrup, Denmark). The cryostat sections were air-dried for 20 min,
¢xed in ice-cold acetone for 10 min and either stained immediately or
stored at ^201C. To determine phenotype, distribution, and number of
the di¡erent leukocyte subsets, single or multicolor immunostaining was
performed. The monoclonal antibodies used in this study and their source
are shown inTable I.
Single staining was performed as follows. Puri¢ed/biotinylated
antibodies were mixed with 2% bovine serum albumin (Sigma-Aldrich,
St Louis, Missouri) in phosphate-bu¡ered saline (Gibco, Invitrogen
GmbH, Lofer, Austria) and applied to frozen sections in a humid
chamber overnight at 41C. After washing with phosphate-bu¡ered saline,
primary antibody binding was visualized by incubating the sections with
either streptavidin^£uorescein (1/100; Amersham Pharmacia Biotech UK
Limited, Cardi¡, UK) or rhodamine (TRITC)-conjugated A⁄niPure
F(ab0)2 fragment goat anti-mouse IgG (Hþ L) (1/200; Jackson Immuno-
Research Laboratories,West Baltimore, Pennsylvania) for 45 min at room
temperature. After washing, slides were placed in 96% ethanol, mounted
in Vectashield Mounting Medium (Vector Laboratories, Burlingame,
California) and cover-slipped.
To characterize further the in¢ltrate of lesional skin, we carried out
double or triple stainings, respectively. The ¢rst step of the multicolor
staining procedure was performed as described above. After washing, the
slides were incubated for 20 min with normal mouse serum (DAKO) to
diminish background problems. Afterwards the secondary antibody,
either biotinylated or £uorescein isothiocyanate (FITC) labeled, was
applied to the sections for at least 6 h at 41C. To prevent FITC-labeled
antibodies from early fading, another staining step was performed with
Oregon Green-labeled goat IgG anti-FITC (1/300; Molecular Probes,
Eugene, Oregon) for 30 min at room temperature. Sections stained with
biotinylated antibodies were further incubated for 45 min with
streptavidin TRITC (1/200; Jackson ImmunoResearch Laboratories) to
visualize antibody binding. For triple stainings, incubation with
biotinylated monoclonal antibodies together with FITC-labeled
monoclonal antibodies for 60 min at room temperature was followed
by simultaneous incubation with streptavidin Cy5 (1/250; Jackson
ImmunoResearch Laboratories) and Oregon Green-labeled goat IgG anti-
FITC fraction for 45 min at 201C.
In all staining experiments, substitution of the primary antibodies with
isotype-matched IgG or IgM (puri¢ed, biotinylated, or FITC labeled) and
omission of the primary antibody served as negative controls.
Evaluation of immuno£uorescence results Biopsy specimens were
read in a blinded fashion at 400  magni¢cation by two independent
investigators using a £uorescence microscope (ocular 10  /25; Axiophot,
Zeiss, Oberkochen, Germany) equipped with a ¢lter for double stainings.
The mean observer coe⁄cient was under 10%.
Skin-in¢ltrating leukocytes were quanti¢ed separately in the epidermis
and dermis, respectively. Labeled cells were enumerated per visual ¢eld and
expressed as the number of cells ( SEM) per mm/basement membrane
epidermis and per mm2 dermis. Only cells clearly positive for the antigen
of interest were counted. Statistical signi¢cance was determined by
Student’s t test. Confocal immuno£uorescence microscopy (LSM 510,
Zeiss) was used to evaluate triple stainings and to document the sites of
preferential expression.
Flow cytometry Punch biopsies (3  6 mm) from patients with
positive EPT were cut into small pieces and incubated in 50 mL tubes
with RPMI 1640 medium for 2 h at 371C. Cell suspensions were prepared
by mincing the skin through a cell strainer. For three-color immuno-
staining, cells were washed in ice-cold phosphate-bu¡ered saline, resus-
pended in blocking reagent (Octagam 5 mg per mL; Octapharma,
Vienna, Austria) and preincubated at 41C for 20 min. Cells were then
incubated on ice for 15 min with anti-CD123 PE (Becton Dickinson, San
Jose, California) combined with anti-MHC II PerCP (Becton Dickinson)
and several FITC-labeled antibodies (anti-CD45RA FITC (Becton Dickin-
son), anti-BDCA-2 FITC (Miltenyi Biotech GmbH, Bergisch Gladbach,
Germany), anti-CD62 ligand (anti-CD62L) FITC (PharMingen), anti-
cutaneous lymphocyte antigen (anti-CLA) FITC (PharMingen, Heidel-
berg, Germany), anti-CD83 FITC (Immunotech, Coulter, Marseille; France),
Table I. List of monoclonal antibodies used in the study
Antibody speci¢city Clone and source of antibodies Isotype
CD4 SK 3; BD, San Jose, CA mIgG1
CD4 FITC RPA-T4; PharMingen, BD
Biosciences, Heidelberg, Germany
mIgG1
CD8 C8/144B; DAKO, Glostrup, Denmark mIgG1
CD3 FITC SK-7; BD mIgG1
g/d TCR 5.A6.E9; Endogen,Woburn; MA mIgG1
CD45RA L48; BD mIgG1
CD45RA FITC ALB11; Immunotech, Coulter,
Marseille, France
mIgG1
CD25 2A3; BD mIgG1
CD25 FITC M-A251; PharMingen mIgG1
CTLA-4 PE BNI3; PharMingen mIgG2a
CD56 (biot) My31; BD mIgG1
CD94 HP-3D9; PharMingen mIgG1
CD15 VIM16; kindly donated by Otto Majdic
(Department of Immunology,Vienna
Medical School)
rIgM
CD14 MFP9; BD mIgG2b
CD1c M241; Ancell, Bayport, MN mIgG1
CD1a M2120; PeliCluster; CLB,
the Netherlands
mIgG2b
Langerin DCGM4; Immunotech mIgG1
MHC II FITC L243; BD mIgG2a
CDw123 9F5; PharMingen mIgG1
BDCA-2 FITC AC144; Miltenyi Biotech
GmbH, Germany
mIgG1
CD62L SK11; BD mIgG2a
CD62L FITC Dreg 56; PharMingen mIgG1
PNAd MECA-79; PharMingen rIgM
CLA FITC HECA-452; PharMingen rIgM
CD83 HB15e; PharMingen mIgG1
CD83 FITC HB15a; Immunotech mIgG2b
CD86 FITC HA5.2B7; Immunotech mIgG2b
CD117 95C3; An der Grub GmbH, Austria mIgG1
ECP EG1; Kabi Pharmacia Diagnostics, Sweden mIgG1
FceRI 15.1 (Ref.Wang et al, 1992) mIgG1
Ki-67 Ki-S5; DAKO mIgG1
CXCR3 49801.111; R&D Systems GmbH,
BiomedicaVienna
mIgG1
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and anti-CD86 FITC (Immunotech). Alternatively, the anti-MHC II
PerCP antibody was replaced by anti-CD4 PerCP (Becton Dickinson).
Following incubation with the indicated monoclonal antibodies, cells
were washed twice with ice-cold phosphate-bu¡ered saline and subjected
to £ow cytometric analysis using a FACSCalibur £ow cytometer (Becton
Dickinson). In order to compare characteristics of skin-derived and blood-
derived plasmacytoid dendritic cells (pDC), peripheral blood mononuclear
cells were obtained simultaneously from the same allergic donors by
Ficoll-Paque density gradient centrifugation (Histopaque-1077, Sigma).
Peripheral blood mononuclear cells were stained and analyzed as
described for cutaneous cell suspensions.
RESULTS
Number and distribution of leukocytes in allergic patch test
reactions In this study we aimed at giving a detailed view of
the di¡erent cell types orchestrating the eczematous reaction in
the e¡ector phase of human ACD. Biopsies from positive 72 h
EPT reactions (n¼10) and NS (n¼ 5) were subjected to
immuno£uorescence analysis using a broad panel of antibodies
(Table I). The results are shown in Table II. When cryostat
sections from NS were incubated with the pan-leukocyte
marker CD45, relatively few cells were detected in both the
epidermis and the dermis. Further stainings revealed that these
cells mainly represent CD1aþ DC in the epidermal compart-
ment, as opposed to CD3þ T cells, CD14þ macrophages,
CD1cþ DC as well as CD117þ mast cells in the dermal com-
partment (Table II). In 72 h EPT, by contrast, we found a
massive leukocytic in¢ltrate (CD45þ cells) in both layers. As
compared with NS, the number of CD45þ cells was nearly
doubled in the epidermal compartment, and increased 5-fold in
the dermis (Table II). In their majority, they represented Tcells or
belonged to the DC family. Besides, we also noted an increased
presence of mast cells, neutrophils (CD15þ), and eosinophils
(EG1þ) when compared with NS.
T cells represent the predominant population in 72 h EPT
specimens The overwhelming majority of the in¢ltrating cells
in the epidermis and dermis of 72 h EPT reactions consist of
CD3þ cells. Figure 1 shows that two-thirds of these T cells
belong to the CD4þ and one-third to the CD8þ subset. Only
a negligible proportion of T cells was CD3þ/CD4^/CD8^ (Fig 1)
and we did not detect any CD4þ/CD8þ T cells (data not
shown). As recent ¢ndings describe a regulatory role for gd-T
cells in murine CHS (Guan et al, 2002), we searched for the
presence of such T cells in human ACD and correlated their
number to the more frequently occurring ab-T cell receptor-
bearing cells. Although the great majority of in¢ltrating T cells
in the dermis of EPT lesions expressed the ab-T cell receptor
(data not shown), a distinct number of T cells also displayed
anti-gd-T cell receptor reactivity (11.9 per mm2 dermis) (Table
II). Double stainings with the proliferation marker Ki-67 and
CD3 yielded negative results (data not shown), indicating that
the increase in T cells in EPT lesions is due to their in£ux from
the peripheral blood and does not result from local expansion of
resident T cells.
Approximately 5% of all dermal CD4þ cells also reacted with
anti-CD25 (IL-2Ra-chain) (data not shown). As these molecules
are also known to be expressed by activated DC and
macrophages, £ow cytometric analysis of single cell suspensions
from 72 h EPT reactions was performed with non-T cells being
excluded by means of a T cell-speci¢c morphogate. These
examinations revealed a CD4þ/CD25þ T cell subset (appro-
ximately 30%) that coexpresses CTLA-4. CD4þ/CD25^ T cells,
by contrast, hardly expressed any CTLA-4 (Fig 2A). Confocal
microscopy of immuno£uorescence triple stainings con¢rmed
these results by showing sizeable numbers of CD4þ/CD25þ/
CTLA-4þ cells in situ (Fig 2B). To learn about the kinetics of
in¢ltrating CD4þ/CD25þ cells, EPT reactions obtained at 0, 24,
48, and 72 h past hapten challenge were comparatively examined
(Fig 2C). At 24 h past challenge, we already observed
considerable numbers of CD4þ T cells, but only very few of
them displayed anti-CD25 reactivity (Fig 2C). After 48 h,
however, the relative contribution of CD25þ cells to the entire
CD4þ T cell in¢ltrate had substantially increased (Fig 2C).
Table II. Number of leukocytes occurring in 72 h EPT lesions and NSa
Epidermis (positive cells per mm) Dermis (positive cells per mm2)
Cell type Antigen(s) Normal skin 72 h EPT Normal skin 72 h EPT
Pan-leukocytes CD45þ 14.1 (12.1^17.7) 30.8 (21.5^50.6) 86 (64.7^97.6) 435.3 (240.6^858)
T cells CD3þ 2.7 (0^3.5) 20.9 (3.7^43.2) 39.5 (2.4^58.4) 513.1 (109.3^896)
DN Tcellsb CD3þ/CD4^/CD8^ 0 (0) 0.4 (0^6.1) 0 (0^1) 14.4 (7.6^24.7)
Helper T cells CD3þ/CD4þ 2.3 (0^2.9) 16.8 (3.2^29.2) 20.4 (2.4^45.2) 396.7 (83^696.8)
Cytotoxic T cells CD3þ/CD8þ 0.6 (0.3^0.9) 6.7 (0.5^13) 8.6 (3.2^44.4) 133.9 (26.3^363.4)
gdT cells gd-TCRþ 0. (0) 1 (0^6.4) 2.2 (0^3.7) 11.9 (2.2^36.6)
Te¡/Tregc CD4þ/CD25þ 0 (0) 2.2 (1.6^11.2) 3.2 (1.3^5.2) 21 (9.7^53.8)
Natural killer T cells CD94þ/CD3þ 0 (0) 0 (0^3.1) 0.7 (0^1.6) 10.1 (3.2^19.4)
Natural killer cells CD94þ 0 (0) 1.9 (0^5.2) 2.4 (0.4^8.2) 39.7 (12.2^217.6)
Natural killer cells CD56þ 0 (0) 0.2 (0^5.3) 7.7 (3.7^19.7) 23.1 (8.1^115.1)
pDC CD123þ/CD45RAþ 0 (0) 3.5 (0^6.5) 1.4 (0^2.8) 39.8 (14.6^85.8)
Langerhans cells Langerinþ 27.7 (18.2^32.8) 18 (13.3^21.5) 1.1 (0.9^3.2) 17.5 (1.1^28.1)
Langerhans cells CD1aþ 18.7 (14.1^24.3) 12.1 (4.1^20.3) 13.5 (10.9^31.4) 44.5 (20.6^95.7)
DDC CD1cþ 4.45 (1.6^7.7) 16.6 (3^26.3) 24 (11.6^49) 97.1 (53^164.5)
IDEC/IDDCd CD1aþ /CD1cþ 0.5 (0^2.4) 5.2 (1.4^8.2) 2.3 (1.1^20.4) 18.9 (4.8^43.5)
Mature Langerhans cells CD1aþ /CD83þ 0.7 (0^1.6) 3.5 (1^6.4) 0.9 (0^1.8) 14.9 (9^40.9)
Mature DDC CD1cþ/CD83þ 1 (0.2^2) 1.4 (0.8^2.3) 5.9 (1.6^17.2) 11 (3.7^14.8)
Mast cells CD117þ (c-Kit) 0 (0) 0 (0) 18.5 (6^40.3) 31.1 (14.7^54.5)
Macrophages CD14þ 0 (0^1) 1.9 (0^3.8) 15.2 (9.7^25.8) 30.6 (14.8^51)
Neutrophils CD15þ 0 (0) 0 (0^6.4) 0 (0) 29.8 (4.8^167.7)
Eosinophils EG1þ 0 (0) 0 (0) 0 (0) 21.5 (1.1^37.6)
aCells were visualized using the indicated markers and evaluated by immuno£uorescence analysis. Numbers indicate median and range (described in brackets) of cells
counted in 10 EPT reactions and ¢ve NS biopsies.
bDouble-negative T cells.
c T e¡ector cells/T regulatory cells.
dIn£ammatory epidermal/dermal dendritic cells.
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These ¢ndings may re£ect a delayed in£ux of the CD4þ/
CD25þ subset from peripheral blood. Alternatively, CD4þ/
CD25þ cells may evolve after 48 h from those CD4þ T cells
that had already entered the skin 24 h after challenge.
The CD4þ/CD25þ T cell subset may represent either acti-
vated e¡ector or regulatory T cells ( Jonuleit et al, 2001a) and
could thus function either to enhance or limit the allergen-
speci¢c in£ammation. Unfortunately, limitations in cell num-
bers did not allow us to investigate the functional properties of
this cell population.
Alterations in DC subsets in 72 h EPT lesions Langerin and
CD1a were used as markers for Langerhans cell, CD1c for DDC
of myeloid origin and CD123/CD45RA for the recently
described pDC (Cella et al, 1999). Under physiologic circum-
stances, we found large numbers of CD1aþ and Langerinþ DC
(18.7 and 27.7 per mm) in the epidermal and moderate numbers
of CD1cþ DC (24 per mm2) in the dermal compartment of
human skin (Table II and Fig 3). Only few CD1cþ cells (4.5
per mm) could be detected in the epidermis (Fig 3A). In 72 h
EPT lesions the situation had changed completely (Fig 3B). The
number of dermal CD1aþ cells (44.5 per mm2) was signi¢cantly
increased at the expense of their epidermal counterpart (12.1 per
mm basement membrane). Nevertheless, the number of CD1aþ
cells in total (epidermis and dermis) was larger in EPT, when
compared with NS (Fig 3).We also noted an immense increase
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Figure1. Increase of T cells in the epidermis and dermis of 72 h
EPT lesions. Frozen tissue sections of NS and EPT lesions were subjected
to immuno£uorescence analysis. Tcells and their subpopulations in the (A)
epidermal and (B) dermal compartment were characterized with either
anti-CD3 alone, anti-CD3 (FITC)/anti-CD4 (TRITC), or anti-CD3
(FITC)/anti-CD8 (TRITC) double stainings. DN T cells were identi¢ed
with anti-CD4 (TRITC) and anti-CD8 (TRITC) followed by anti-CD3
(FITC). Only cells showing a clear reactivity were scored as positive. Data
represent the mean number of Tcells SEM of 10 EPTreactions and ¢ve
NS biopsies. Statistical signi¢cance was determined by Student’s t test
(po0.012).
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Figure 2. Detection of CD4þ/CD25þ T cells in the in£ammatory
in¢ltrate of EPT lesions. (A) Epidermal/dermal cell suspensions of biop-
sies from 72 h EPT lesions were prepared and subjected to FACS analysis.
To exclude macrophages or DC from the analysis, T cells were de¢ned in
the corresponding morphogate. CD4þ T cells were assessed for positive
immunoreactivity with anti-CTLA-4 and anti-CD25. Signi¢cant expres-
sion of CTLA-4 was only found on CD25þ, but not on CD25^ T cells.
Data are representative of three experiments. (B) In situ triple staining of
CD4þ (FITC)/CD25þ (TRITC) cells in 72 h patch test reactions. Arrows
denote cells with triple positive immunoreactivity (whitish). (C) Kinetics
of in¢ltrating CD4þ/CD3þ and CD4þ/CD25þ T cells. Biopsies ob-
tained at four di¡erent time points past hapten challenge (0 h, 24 h, 48 h,
72 h) were subjected to immuno£uorescent analysis. Cells double-positive
for either CD4/CD25 or CD4/CD3 were evaluated. CD4þ/CD3þ T cell
in¢ltration into the dermal compartment started early (upper graph), and
preceded that of CD4þ/CD25þ cells by 24 h (lower graph).
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in the amount of CD1cþ cells compared with NS, not only in
the dermis (97.1 per mm2), but also in the epidermis (16.6 per
mm) (Fig 3). Closer investigation revealed coexpression of
CD1a in approximately 25% of both epidermal and dermal
CD1cþ cells (Table II). These cells could either represent
in£ammatory dendritic epidermal cells, or a subpopulation of
Langerhans cells (Lenz et al, 1993;Wollenberg et al, 1996).
To distinguish between immature and mature DC present in
in£amed skin, we performed in situ double stainings with the
activation/maturation marker CD83. As opposed to NS with
only few CD1aþ cells expressing CD83 (3.6% of epidermal and
4.3% of dermal CD1aþ cells), we found a substantial proportion
of mature Langerhans cells present in EPT lesions (28% of
epidermal and 38.1% of dermal CD1aþ cells) (Fig 4). In
contrast, the vast majority of CD1cþ cells remained CD83^
(91% of epidermal and 90% of dermal CD1cþ cells) (Fig 4).
We also detected a small number of the newly de¢ned
CD123þ/CD45RAþpDC population in the dermal, but not in
the epidermal compartment of NS (1.4 per mm2). Interestingly,
these cells represented a substantial proportion of the entire DC
in¢ltrate (39.8 per mm2) in EPT lesions (Fig 3).
Phenotypic features of pDC in ACD lesions In humans,
pDC can be identi¢ed by the coexpression of CD123 and
CD45RA, BDCA-2, CD68, CXCR3, and CD62L (Cella et al,
1999; Dzionek et al, 2001; Farkas et al, 2001; Wollenberg et al,
2002). To learn more about the phenotypic characteristics of
pDC in NS and EPT lesions, we performed double and triple
stainings with the indicated markers (Figs 5, 6, and 7A^C). In
NS, pDC could barely be detected. The epidermis was devoid
of pDC, and in the dermis we found a few scattered cells
with positive immunoreactivity for CD123/CD45RA, CD123/
BDCA-2, and CD123/CD68 (Fig 5). Lesional skin, in contrast,
contained pDC in both the epidermal and dermal compartment
(Fig 5).Whereas CD123þ cells showed a comparable coexpression
of CD45RA (median (m)¼ 3.5 per mm epidermis and 39.8 per
mm2 dermis), BDCA-2 (m¼1.6 per mm and 32.8 per mm2),
and CD68 (m¼ 2.3 per mm and 24 per mm2), CD62L (L-
selectin) was merely present on one-third of the pDC
population (m¼ 0.4 per mm and 8.5 per mm2) (Figs 5 and
7A,B). As local proliferation of pDC was excluded by double
stainings with BDCA-2 and the proliferation marker Ki-67
(data not shown), these ¢ndings may re£ect a cutaneous in£ux
of blood-derived pDC that downregulate CD62L after their
entry into skin. To characterize skin-derived pDC better, we
performed £ow cytometric analysis of single cell suspensions
from biopsies of 72 h EPT lesions and compared them with
peripheral blood-derived pDC of the same patient (Fig 6).
Approximately 90% of the gated CD123þ/CD45RAþ cell
population in both the skin and the blood were positive for
CD4 and/or MHC II (Fig 6A).When gating on CD123þ/MHC
IIþ cells, the population showed homogeneous surface expres-
sion of BDCA-2 in the skin and in the blood (Fig 6B). Blood-
derived CD123þ/MHC IIþ cells did not react with the
maturation-de¢ning anti-CD83 and anti-CD86 antibodies
(Kohrgruber et al, 1999). In contrast, we found approximately
50% mature CD83- and CD86-bearing cells within the pDC
population in¢ltrating the skin (Fig 6B).
Searching for mechanisms involved in pDC adhesion to
endothelial cells and migration from peripheral blood to skin,
we found CLA expression on approximately 80% of skin and
95% of blood-derived pDC (Fig 6B). Adhesion of CLAþ pDC
could be mediated by binding to E-selectin, as this corresponding
ligand is known to be strongly upregulated on venules in
in£ammatory cutaneous lesions such as CHS (Picker et al, 1991;
Harari et al, 1999). Circulating pDC gain access into regional
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Figure 3. Distribution of Langerhans cells, DDC, and pDC in the
epidermis and dermis of 72 h EPT lesions and NS.We subjected fro-
zen sections to immuno£uorescence analysis and characterized the various
DC subsets. Single stainings were performed to identify Langerhans cells
(Langerin and CD1a) and DDC (CD1c), double stainings to visualize pDC
(CD123 FITC/CD45RA TRITC) in the epidermis (A) and dermis (B) of
NS and 72 h EPT. Only cells showing a clear immunoreactivity were
scored as positive. Statistical signi¢cance was determined by Student’s t test
(po0.005; po0.025).
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Figure 4. Proportion of CD83þ cells in CD1aþ and CD1cþ popu-
lations in the skin. The maturation/activation of Langerhans cells and
DDC in healthy skin and in 72 h EPT reactions was investigated by visua-
lizing CD1aþ /CD83þ and CD1cþ/CD83þ cells by immuno£uorescence.
Left graphs: In EPT lesions there is a signi¢cant increase in the number of
dermal CD1aþ cells (grey bars) at the expense of their epidermal counter-
part in EPT lesions. In contrast to NS, which contains only a small percen-
tage of CD1aþ /CD83þ cells (black bars) in the epidermal (upper graph)
and dermal compartment (lower graph), a substantial proportion of
CD1aþ /CD83þ cells (black bars) was found in the epidermis and dermis
of EPT lesions. Right graphs: The number of CD1cþ DDC (grey bars) is
increased in the epidermis (upper graph) and dermis (lower graph) of EPT
reactions compared with NS. In contrast to Langerhans cells, the majority
of DDC remains negative for CD83 after-hapten challenge (black bars).
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lymph nodes via ligation of CD62L to the peripheral lymph
node vascular addressin (PNAd), expressed on endothelial cells
of high endothelial venules (HEV) (Cella et al, 1999). As
expected, almost 100% of blood-derived pDC were strongly
CD62Lþ , whereas the expression level on skin-derived pDC
varied from low to intermediate (Fig 6B). The downregulation
of CD62L on skin-derived pDC is in accordance with our in situ
¢ndings (Fig 5). To investigate whether pDC could indeed enter
EPT lesions via CD62L, we searched for the presence of PNAd
on vascular endothelium (Lechleitner et al, 1999) and found a
small proportion of endothelial cells displaying positive MECA-
79 reactivity in 72 h EPT lesions (data not shown). A subset of
CD123þ pDC also coexpressed the chemokine receptor
CXCR3 (Fig 7C) and may therefore be attracted by activated
skin cells secreting CXCR3 ligands (Sebastiani et al, 2002). In
summary, these results are indicative of a substantial in£ux of
CD62Lþ/CLAþ pDC into 72 h EPT lesions, partially
undergoing maturation in in£amed skin.
Emergence kinetics of pDC To investigate the emergence and
disappearance kinetics of in¢ltrating pDC, time course
experiments were performed. The evaluation of CD123þ/
CD45RAþcells in EPT reactions revealed an increase in cell
number at 24 h past challenge (0.7 per mm epidermis and 17.4
per mm2 dermis), which peaked at 48 h (1.2 per mm epidermis
and 28.2 per mm2 dermis), and then decreased again (Fig 8A).
Examinations of skin biopsies at even earlier time points past
challenge (6 h and 12 h) also showed a clear increase in the
number of pDC compared with unchallenged skin (data not
shown).
Proximity of pDC and natural killer cells in EPT
lesions The early appearance of this cell type in the elicitation
phase of ACD, the fact that pDC play a part in linking innate and
adaptive immunity (Colonna et al, 2002), and recent ¢ndings on
the role of cells of the innate immune system in murine CHS
(Tsuji et al, 2000) prompted us to search for the presence of
other prominent members of innate immunity, namely natural
killer and natural killer T cells.We identi¢ed natural killer cells
in EPT lesions by using antibodies against CD56 and CD94
(Table II) and were surprised to observe a higher number of
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Figure 5. Phenotypic characterization of pDC. NS and 72 h EPT
lesions were phenotypically analyzed by double stainings for CD123/
CD45RA, CD123/BDCA-2, CD123/CD68, and CD123/CD62L. Contrary
to EPT, the epidermis of NS is devoid of pDC. Pronounced increase in the
number of dermal CD123þ/CD45RAþ , CD123þ/BDCA-2þ , and
CD123þ/CD68þ cells in ACD when compared with NS. Note that only
few CD123þ cells express CD62L. Statistical signi¢cance was determined
by Student’s t test (po0.01).
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Figure 6. Flow cytometric analysis of cell suspensions of EPT lesions and peripheral blood mononuclear cells. (A) Skin- and blood-derived
pDC display CD123/CD45RA/CD4/MHC II on their surface. CD123þ/CD45RA^ and CD123þ/CD45RAþ cell populations were gated and analyzed for
the expression of CD4 and MHC II. (B) Comparison of the expression of adhesion molecules and maturation markers on CD123þ/MHC IIþ cells in skin
and blood.Whereas CLA is displayed on skin- and blood-derived pDC in a comparable fashion, we ¢nd that approximately 30% of skin-derived pDC have
lost CD62L on their surface. In contrast to blood-derived pDC there is abundant expression of the maturation markers CD83 and CD86 on skin-derived
pDC.
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CD94þ cells when compared with CD56þ cells. Characteriz-
ing natural killer T cells, we found that approximately one-
fourth of all CD94þ cells bore the T cell receptor (Table II),
whereas CD56þ cells remained CD3^ (data not shown). This
CD94þ/CD3þ/CD56^ natural killer T cell subset may account
for the numerical di¡erence between the CD56þ and the
CD94þ cells.
Interestingly, the in¢ltration kinetics of CD56þ natural killer
cells resembled those of pDC (Fig 8B) with an increase in natural
killer cells to 13.7 cells per mm2 in the dermal compartment at 24
h, a peak at 48 h (21.8 per mm2) and a decrease at 72 h after
challenge. Only a negligible number of CD56þ cells was
encountered in the normal dermis (3.9 per mm2) (Fig 8B,Table
II). Triple stainings of EPT lesions not infrequently revealed a
close proximity of CD123þ/MHC IIþ pDC and CD56þ cells
in the perivascular in¢ltrate of the dermis (Fig 7D).
DISCUSSION
Whereas abundant knowledge exists about the cellular and mo-
lecular events operative in the sensitization phase of CHS, the un-
derstanding of the mechanisms guiding the elicitation phase
remains incomplete (Sinigaglia et al, 1985; Probst et al, 1995). To
learn more about antigen-presenting cells directing T cell re-
sponses in this process, we have phenotypically analyzed the leu-
kocytic in¢ltrate of EPT reactions, with special emphasis on DC
and T cell subsets. In this context, we describe the occurrence of
pDC in EPT lesions and correlate their number and level of acti-
vation with that of Langerhans cells and DDC.
Notwithstanding their decisive function in the induction phase
of CHS (Romani and Schuler, 1992), the role, if any, of Langer-
hans cells in the e¡ector phase is a matter of controversy (Grabbe
et al, 1995). On the basis of CD1a and Langerin expression we
compared the numbers of Langerhans cells residing in NS and
EPT lesions and found a signi¢cant decrease of epidermal and
an increase of dermal Langerhans cells in lesional skin. The ma-
jority of these Langerhans cells expressed the maturation marker
CD83, possibly as a consequence of hapten challenge. It should be
emphasized that the number of CD1aþ cells exceeded that of
Langerinþ cells in the epidermis and dermis of ACD lesions,
raising the question as to the nature of these cells. Three possibi-
lities can be entertained to explain this phenomenon. They could
either represent peripheral blood-derived CD1aþ /Langerin^ pre-
cursor cells, CD1aþ /CD1cþ in£ammatory dendritic epidermal
cells, or Langerhans cells migrating to the draining lymph nodes
after hapten challenge. (Wollenberg et al, 1996). Antigen could
also be captured and presented by DDC, a subset of DC with
myeloid origin displaying positive reactivity for CD1c (Lenz
et al, 1993; Cella et al, 1997).We found a dense dermal in¢ltrate of
CD1cþ cells with the majority resting in an immature state
(CD1cþ/CD83^). Based on these ¢ndings we hypothesize that
mature Langerhans cells present antigen to hapten-speci¢c e¡ec-
torTcells and thereby initiate and propagate the allergic response.
Immature DDC, in contrast, may possibly activate regulatory T
cells (Jonuleit et al, 2001b), which, in a delayed fashion, would
then be responsible for the resolution of the eczematous reaction.
Importantly, we demonstrated the existence of a signi¢cant
number of CD123þ/CD45RAþ cells in the dermis of human
ACD lesions. Their additional expression of high levels of
CD68, MHC II, and BDCA-2 quali¢ed them clearly as pDC.
Based on their negative immunoreactivity for Ki-67, we would
assume that pDC or their precursors enter the skin upon hapten
challenge and do not proliferate locally. A sizeable number of
pDC could already be observed in 6 h EPT lesions. Searching
for possible mechanisms involved in pDC adhesion to the en-
dothelium and migration from blood to skin, we investigated
surface expression of CLA, CD62L, and CXCR3. Notably, pDC
displayed almost uniform expression of the skin-homing mole-
cule CLA before (95%) and after (80%) skin entry. In addition,
almost 100% of the circulating pDC isolated from nickel-allergic
individuals were highly CD62Lþ , yet the expression level of this
adhesion molecule was signi¢cantly reduced after entry into skin.
Similar observations were made in human lymph nodes, where
CD62L is cleaved completely from the surface of pDC after entry
via HEV (Cella et al, 1999).We hypothesize that pDC may adhere
to endothelial cells via CLA/E-selectin and CD62L/PNAd inter-
actions (Picker et al, 1991; Lechleitner et al, 1999), as we found ves-
sels in EPT lesions to be positive for these addressins (data not
shown). Our ¢ndings of CXCR3 on a subset of lesional pDC
suggest that the ligands of this chemokine receptor, i.e., CXCL9
(MIG), CXCL10 (IP-10), and CXCL11 (ITAC), are involved in at-
tracting pDC to the skin.This is in line with recent data showing
that pDC have the capacity to migrate in response to CXCR3/
CXCR4 ligands (Krug et al, 2002).
Similar to Langerhans cells and DDC, pDC are capable of sti-
mulating antigen-speci¢c T cell proliferation (Kohrgruber et al,
1999; Cella et al, 2000). As evidence exists that the state of DC
activation determines the type of T cell response (proliferation/
anergy) (Steinman et al, 2003), we were interested in the matura-
tion pro¢le of skin-derived pDC. Flow cytometric analysis of
single cell suspensions revealed reactivity for the maturation mar-
kers CD83 and CD86 in approximately 50% of skin-derived
pDC, but not blood-derived pDC, indicating that after leaving
the blood, pDC undergo, at least partly, a process of maturation
and acquire the ability to activate skin-in¢ltratingTcells. Human
in vitro studies have shown that, dependent on the type of matura-
tion stimuli, i.e., viral products or IL-3/CD40 ligand (CD40L),
pDC have the capacity to prime either for a T helper type 1 or 2
biased immune response (Rissoan et al, 1999; Kadowaki et al,
2000). In EPT lesions IL-3 may be secreted by activated mast cells
(Plaut et al, 1989), whereas CD40L could conceivably be provided
by in¢ltrating T cells. In this context, it should be noted that
CD40L-activated murine pDC also have the capacity to induce
a CD8þ T regulatory cell di¡erentiation (Gilliet and Liu, 2002).
The exact function of immature and mature pDC in EPT reac-
tions is currently under investigation.
We found the massive T cell in¢ltrate in 72 h EPT to be
dominated by CD4þ T cells (CD4þ/CD8þ T cells ratio 2:1),
which, according to other studies, mainly express ab-T cell re-
ceptors (Sterry et al, 1990; Brasch et al, 1992). Only few T cells
showed a positive reactivity for gd-T cell receptor. Interestingly,
we detected a CD4þ T cell subset coexpressing CD25 and
CTLA-4 within lesional, but not NS. The late occurrence of
this CD4þ/CD25þ T cell population (48 h past challenge),
when compared with CD4þ/CD25^ Tcells (24 h past challenge),
may either re£ect its delayed in£ux from the peripheral blood or
the evolvement from CD4þ/CD25^ T cells that had entered the
skin earlier.Whether the CD4þ/CD25þ T cell subset represents
activated e¡ector, allergen-speci¢c regulatory T cells (Tr cells)
(Cavani et al, 1998) or nonspeci¢c suppressor T cells (Jonuleit
et al, 2001a; Shevach, 2002) and, thus, functions to either en-
hance or limit the allergen-speci¢c in£ammation, remains to be
determined.
Besides characterizing members of the adaptive immune sys-
tem, we also describe the occurrence of cells of the innate im-
mune system such as natural killer cells, neutrophils, mast cells,
macrophages, and eosinophils in the dermal compartment of
72 h EPT lesions. These cells may be attracted and activated by
proin£ammatory cytokines produced by keratinocytes in re-
sponse to hapten challenge as a line of ¢rst defense (Luger and
Schwarz, 1990; Barker et al, 1991). Investigation of the kinetics of
natural killer cells and their location within the leukocytic in¢l-
trate revealed a migration pro¢le very similar to that of pDC and,
additionally, a close proximity to pDC. It is tempting to speculate
about a cross-talk between pDC and natural killer cells in the ef-
fector phase of ACD, similar to what has been described for ato-
pic dermatitis (Buentke et al, 2002). By producing large amounts
of interferon-a, pDC may not only provide an autocrine survival
factor (Kadowaki et al, 2000), but also contribute to stimulation
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Figure 7. Immuno£uorescence double- and triple stainings with pDC-de¢ning markers. (A) Visualization of pDC in the papillary dermis by
using antibodies against CD123 (red)/BDCA-2 (green) (original magni¢cation  1000), CD68 (red)/CD123 (green) (original magni¢cation  600) as
well as CD45RA (red)/CD123 (green) (original magni¢cation  600).The merge of double-stained cells appears in yellow. (B) We con¢rmed the presence
of pDC in lesional skin by triple stainings for either CD45RA (red), CD123 (blue), and BDCA-2 (green) (original magni¢cation  1000) or CD45RA
(red), CD123 (blue), and CD4 (green) (original magni¢cation  400). Merging of three-colored cells results in a whitish color (small arrows). (C) Triple
stainings for CD45RA (red), CD123 (blue) and MHC II (green) (original magni¢cation  600) (a) and for CXCR3 (red), CD123 (blue) and MHC II
(green) (original magni¢cation  400) (b). Both pictures show triple-positive cells within the perivascular in¢ltrate in EPT lesions. Small arrows delineate
triple stained cells, big arrows denote CD123þ vessels. (D) Natural killer cells (red) (visualized by CD56) and pDC (green/blue) (visualized by CD123/MHC
II) are located in close proximity to each other. Original magni¢cation: (a)  400; (b)  800. Pictures are representative of all evaluated biopsies.
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and subsequent interferon-g production of natural killer cells
propagating aT1-biased response.
Application of nickel to the skin of nonallergic individuals did
not change its cellular composition, indicating that the mere hap-
ten contact is not enough to elicit the occurrence of, for example,
pDC, DDC, and natural killer cells (data not shown). The initia-
tion of the in¢ltrate required in£ammatory signals that could
either be provided by the hapten challenge of a sensitized indivi-
dual or the cutaneous application of contact irritants such as so-
dium dodecyl sulfate (data not shown).
To the best of our knowledge, this analysis is one of the ¢rst to
provide a detailed and synoptic view about the cellular composi-
tion of the in£ammatory in¢ltrate in ACD and its kinetics. This
understanding should now enable us to examine the relative con-
tribution of the various players in the emergence and resolution
of the disease.
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Figure 8. In¢ltration kinetics of CD123þ/CD45RAþ and CD56þ
cells in 72 h EPT lesions. Biopsies obtained at four di¡erent time points
past hapten challenge (0 h, 24 h, 48 h, 72 h) were subjected to immuno-
£uorescent analysis. (A) Simultaneous increase in the number of CD123þ/
CD45RAþ pDC, and (B) CD56þ cells early after challenge with a peak at
48 h.
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